Recent Updates
Recently added Catalysts

Meridian Bioscience Inc

VIVOFDA catalysts, PDUFA dates & pipeline intelligence
$2.96
▼ -0.14 · -4.52%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full VIVO financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
Volume
551.91 K
Value Traded
1.22 M
Short % Float
42.15%
-10.03%Week
-24.1%1 Month
-37.15%3 Month
+10.45%6 Month

Cash Data

Unlock VIVO cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
94.70 M
EPS (TTM)
-0.06
P/E Ratio
-
Ent. Value
-
Total Shares
31.99 M
Float Shares
5.08 M
Insiders
84.11%
Institutions
4.50%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every VIVO catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

VIVO Catalyst Timeline

Dated clinical, regulatory and corporate events for Meridian Bioscience Inc

Catalyst Timeline

Dated clinical, regulatory & corporate events for Meridian Bioscience Inc

21Total events
0Upcoming
8Tier-1 (high impact)
2024 to 2026Coverage

Event history 21

▲Other Regulator MilestoneEx-US Regulatory
Health Canada license granted for Alethia CMV assay
▲ATM ProgramCorporate
Terminated $180M F-3 Registration Statement
◆Management ChangeCorporate
David Mansfield, Keith Loose, and Gary Challinor departing as CFO, CTO, and Company Secretary
▼Equity OfferingCorporate
Completed $30 million PIPE at $6.80 conversion price
▲ATM ProgramCorporate
Termination of At-the-Market Equity Offering Agreement
◆Timing GuidancePresentation
Spin-off of Tembo and Caret Digital targeted to close
◆Quarterly UpdateCorporate
Shareholder meeting to approve private placement
▼Equity OfferingCorporate
US$121 million private placement at US$6.05 per share
▲Partnership / LicenseCorporate
Tembo signs definitive distribution agreement with Green Watt for up to 1,600 EUV units in Saudi Arabia
◆AcquisitionCorporate
VivoPower receives non-binding all-cash takeover proposal from Energi Holdings at $120M enterprise value
Unlock the full VIVO catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How VIVO actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
-Example Drug Phase 3 data readout Phase 3
Unlock all VIVO historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Pipeline Score
Pipeline Value
Valuation Signal
2
Drugs Scored
rNPV / MCap
Top Drug
Top 96%
Micro Cap
(rank 631 of 657)
Percentile Rank
Showing 0 of 8 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
Unlock the VIVO pipeline intelligence model
PTRS, rNPV, enrollment velocity, trial design quality and ML risk signals for every asset above.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every VIVO program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every VIVO trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock VIVO insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
John SmithCEOBuy 50,000 150,000 held$45.50 01/10/2026
Unlock the full VIVO insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
SOLEUS CAPITAL MANAGEMENT, L.P. 0.5 % 3.14 M 163.00 K
Unlock every fund holding VIVO
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in VIVO
Shares held by hedge funds each quarter, and who bought or sold.

VIVO Institutional Ownership Trends

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock VIVO option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live VIVO option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock VIVO options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How VIVO ranks across every disease it competes in

Competitive Position is a premium feature
See how VIVO ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

VIVO News

-VIVO
Jul 14, 2026
VIVOFDA Updates

Meridian Bioscience Announces Health Canada License for Alethia® CMV Assay

Meridian Bioscience, Inc. has received a license from Health Canada for its Alethia® CMV assay. This new addition broadens Meridian's existing Alethia menu, which already includes various assays for other pathogens. The approval enhances the company's molecular diagnostic capabilities in the Canadian market.

Read more →
-VIVO
May 21, 2026
VIVOGeneral
▲ +16.5%on this news

Shortlists AI Tenants for 41.5MW Norway AI Data Center After Receiving Multiple Bids

VivoPower PLC has shortlisted AI tenants for its 41.5MW data center in Mo i Rana, Norway, after a formal request for proposal (RFP) process. The selected tenants are expected to enhance the facility's economic profile beyond current revenues of $31 million. VivoPower values the data center's strategic significance due to its low power costs, which are below US$0.035/kWh. Additionally, there is potential for a 40MW expansion pending regulatory approval within the next 18 to 24 months.

Read more →
-VIVO
Apr 23, 2026
VIVOGeneral
▲ +16.7%on this news

VivoPower Launches Lease Bidding after Receiving Strong Interest from AI Operators for 41.5MW Norway Data Center

VivoPower has launched a lease bidding process for its 41.5MW data center in Mo i Rana, Norway, following significant interest from AI neocloud operators and hyperscalers. The site, which could expand to over 80MW pending regulatory approval, benefits from low power costs due to its operation on renewable energy. VivoPower aims to enhance its data center economics beyond its current annual revenues of $31 million. The selection process will assess prospective tenants based on commercial terms and alignment with VivoPower's operational strategy.

Read more →
-VIVO
Apr 21, 2026
VIVOGeneral
▼ -12.5%on this newsshared move

VivoPower Becomes EBITDA Profitable: $31 Million Revenue, $10 Million EBITDA From Completion of Norway Data Center Acquisition Transaction closed and fully funded for the $41 million acquisition, with no additional publi

VivoPower PLC has announced the successful completion of its acquisition of certain subsidiaries operating a renewable energy-powered data center in Norway. This strategic transaction, finalized at $41 million, significantly enhances VivoPower's financial position, with expected revenue of $31 million and EBITDA of $10 million from the acquired operations. The data center operates with 41.5MW capacity and aims for further expansion, subject to regulatory approval. Additionally, VivoPower is exploring AI computing opportunities to optimize operations in this facility.

Read more →
-VIVO
Mar 20, 2026
VIVOGeneral
▼ -5.5%on this news· ran to +21% by day 3

Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public Float

VivoPower PLC has announced a strategic program to convert 2.96 million Class A ordinary shares into unlisted Class B shares, which are restricted from trading but offer enhanced voting rights. This initiative is part of a broader capital strategy aimed at reducing dilution while aligning with shareholder interests and has been supported by recent acquisitions of shares by board members, including the CEO. The company aims to strengthen its capital structure and governance framework, fostering long-term value creation. This move follows the termination of an equity offering agreement and a registration statement, reinforcing its commitment to non-dilutive capital management.

Read more →
-VIVO
Mar 18, 2026
VIVOGeneral
▲ +18.4%on this newsshared move

Terminates $180 Million F-3 Registration Statement

VivoPower PLC has announced the termination of its Form F-3 registration statement, underscoring its commitment to a non-dilutive capital strategy. The decision, which takes immediate effect, indicates management's confidence in the company's financial outlook and alternative funding avenues. Founded in 2014, VivoPower continues to focus on providing infrastructure solutions for AI compute applications, ensuring sovereign control over energy and data.

Read more →
-VIVO
Mar 16, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Announces Effectiveness of New Stock Ticker "VIVO" and Corporate Name Change

VivoPower International PLC has announced the effectiveness of its new stock ticker 'VIVO' and completed a corporate name change to VivoPower PLC. This strategic rebranding is designed to enhance its focus on building and leasing powered land and data center infrastructure tailored for AI compute applications. The changes are effective immediately and do not require any action from current shareholders. VivoPower continues to aim for providing sustainable data center solutions globally.

Read more →
-VIVO
Mar 10, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Announces New Stock Ticker "VIVO" and Corporate Name Change in Alignment with its Business Focus on AI Data Centers

VivoPower International PLC announced a corporate name change to VivoPower PLC and a new stock ticker 'VIVO', effective March 16, 2026, to better reflect its focus on AI data center infrastructure. This change aims to align the company's identity with its mission of providing sustainable data solutions to sovereign nations. Shareholders will not be required to take any action as their rights remain unaffected. VivoPower's efforts are positioned to bridge the gap between energy assets and AI ambitions on a global scale.

Read more →
-VIVO
Feb 19, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Announces Leadership Changes LONDON

VivoPower International PLC has announced changes to its executive leadership team as part of its strategic focus on powered land and data center infrastructure. The company is advancing its capabilities through recent acquisitions, including a 291MW powered site in Finland and plans for a 25MW data center in the UAE. The departing executives, including the CFO and CTO, are thanked for their contributions. The company aims to continue strengthening its leadership as it builds its sovereign-powered AI data center platform.

Read more →
-VIVO
Feb 12, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

Meridian Secures $30 Million PIPE at $6.80 Conversion Price to Accelerate Sovereign AI Data Center Platform

VivoPower International PLC has completed a $30 million strategic private investment in public equity (PIPE) at a conversion price of $6.80 per share. The investment supports its development of AI data center infrastructure aimed at sovereign nations. Major investors included Blue Sky Capital and sovereign family offices from the Gulf Cooperation Council. The raised funds will facilitate scaling VivoPower's AI data center portfolio and support general working capital needs.

Read more →
-VIVO
Feb 5, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Completes Definitive Agreement with KWeather, Advances Strategic Exit from Digital Asset Holdings with No Realized or Unrealized Losses

VivoPower has completed a definitive agreement with KWeather, which includes KWeather acquiring rights to certain Ripple Lab shares held by VivoPower. In exchange, VivoPower will receive shares worth $4.3 million, representing a 20% stake in KWeather. Additionally, VivoPower confirms it has not incurred any losses from its digital asset holdings and will no longer acquire further digital assets, refocusing its efforts on scaling its data center infrastructure initiatives.

Read more →
-VIVO
Feb 2, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

International PLC Announces Termination of At-the-Market (ATM) Equity Offering Agreement

VivoPower International PLC has announced the termination of its at-the-market equity offering agreement with Chardan Capital Markets. This decision follows a review of the company's financial outlook and capital requirements, indicating confidence in its current cash flow and economic strategies. As a result, no further shares will be issued under the agreement. The company emphasizes a disciplined capital allocation approach to avoid dilutive fundraising.

Read more →
-VIVO
Jan 30, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Announces Shareholder Approval of All Resolutions at Extraordinary General Meeting

VivoPower International PLC announced that all six resolutions presented at its Extraordinary General Meeting have been overwhelmingly approved by shareholders, with each resolution receiving no less than 93% of the votes cast. This approval is expected to enhance the company's flexibility for growth and modernize its capital structure. VivoPower, a B Corp-certified company, focuses on sustainable energy solutions and aims to expand its powered land and data center infrastructure for AI applications.

Read more →
-VIVO
Jan 16, 2026
VIVOGeneral
▼ -94.4%on this newsshared move

Tembo Secures Strategic Partnership in US$11 Billion Australian Utility Pick Up Truck Market with EV Industry Leader HMBEV

VivoPower's subsidiary, Tembo, has formed a strategic partnership with Help Me Buy An EV to enhance the adoption of its electric utility vehicles in Australia. This collaboration aims to accelerate sales and education initiatives in the growing Australian market for light utility vehicles. Through this partnership, Tembo seeks to leverage HMBAEV's reputation and expertise to effectively engage with businesses, government, and commercial sectors, addressing demands for rugged, zero-emission vehicles. This strategic move also supports Tembo’s impending Nasdaq public listing, highlighting its commitment to sustainable and innovative transportation solutions.

Read more →
-VIVO
Jul 1, 2025
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Receives Nasdaq Letter Confirming it is in Compliance with Nasdaq Listing Standard

VivoPower International PLC has received confirmation from Nasdaq that it is now in compliance with the stock listing standards after addressing previous deficiencies in stockholders' equity. The company successfully completed a US$121 million private placement, resulting in gross proceeds of US$60.5 million. VivoPower is shifting its business focus towards digital assets centered on XRP, aiming to enhance the utility of the XRP Ledger. The compliance status will be continually reviewed, and failure to meet future requirements may result in delisting.

Read more →
-VIVO
Jun 26, 2025
VIVOGeneral
▼ -94.4%on this newsshared move

Believes It Meets Nasdaq Equity Requirement Following Reg S Investment

VivoPower International PLC announced that it believes it has regained compliance with Nasdaq equity listing rules following a successful private placement. This placement garnered gross proceeds of US$60.5 million, leading to an estimated pro forma stockholders' equity of approximately US$20 million. The company received prior notification of non-compliance due to an equity deficit, but an extension was granted by Nasdaq to achieve compliance. Moving forward, Nasdaq will continue to monitor VivoPower's status.

Read more →
-VIVO
May 28, 2025
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private Placement Priced at US $6.05 Per Share, Above Last Market Closing Price Under NASDAQ Rules

VivoPower International PLC (NASDAQ: VVPR) has announced a US$121 million private placement priced above the last market closing price, aiming to establish an XRP-focused digital asset treasury strategy. This initiative marks VivoPower as the first publicly listed company to execute such a strategy, with funds raised intended for accumulating XRP and contributing to decentralized finance (DeFi) infrastructure. The capital raise is led by His Royal Highness, Prince Abdulaziz bin Turki Al Saud, alongside other prominent digital asset investors. The transaction's completion hinges on shareholder approvals and market conditions.

Read more →
-VIVO
Apr 14, 2025
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower provides clarification re US$180 million enterprise value takeover proposal takeover offer is a buyout for 8 out of 10 shares held by shareholders at a record date

VivoPower International PLC has provided clarification regarding a proportional takeover offer from Energi Holdings Limited, valuing the company at US$180 million. The offer allows shareholders to sell 8 out of 10 shares they hold at a specified price calculated as US$180 million minus net debt divided by eligible ordinary shares. This update was prompted by shareholder inquiries, and due diligence is currently in progress. The company's prospects remain subject to various market risks and uncertainties.

Read more →
-VIVO
Apr 11, 2025
VIVOGeneral
▼ -94.4%on this newsshared move

Tembo Signs Definitive Distribution Agreement with the Kingdom of Saudi Arabia's Green Watt Worth up to an Estimated US$85 Million

VivoPower's subsidiary, Tembo, has finalized a distribution agreement with Saudi Arabia's Green Watt to sell 1,600 electric utility vehicle units by 2030. This contract, valued at approximately US$85 million, represents Tembo's entry into the rapidly expanding Saudi market for electrification of utility vehicles. Green Watt, an established provider of energy and environmental solutions in Saudi Arabia, will leverage its strong industry connections, including partnerships with major companies like Aramco and Halliburton, to promote Tembo's offering. Both companies emphasize their commitment to advancing sustainable energy solutions in line with regional decarbonization objectives.

Read more →
-VIVO
Mar 24, 2025
VIVOGeneral
▼ -94.4%on this newsshared move

VivoPower Receives Non-Binding All Cash Takeover Offer at Enterprise Value of US$120 Million

VivoPower International PLC has announced the receipt of an unsolicited, non-binding takeover proposal from Energi Holdings Limited, an Emirati energy solutions company. The proposal includes an all-cash offer for all non-affiliated free float shares, valuing the enterprise at US$120 million. VivoPower's board is currently reviewing the proposal with its advisors and plans to provide updates to the market. The company is focused on sustainable energy solutions and has a global presence in various regions.

Read more →

About Meridian Bioscience Inc

41 employees vivopower.com
BIOPHARMAWATCH ELITE PLUS
Trade the next VIVO catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime